Literature DB >> 28032380

MicroRNA-195-5p suppresses osteosarcoma cell proliferation and invasion by suppressing naked cuticle homolog 1.

Qiang Qu1, Xiangdong Chu1, Peng Wang1.   

Abstract

MiR-195-5p has been shown to play an essential role in human cancer progression. Nevertheless, the biological role of miR-195-5p in osteosarcoma development remains unclear. In this study, real-time PCR was performed to examine the miR-195-5p expression in human osteosarcoma cell lines. CCK-8 assay and Transwell assay were carried out to measure the effect of miR-195-5p on cell proliferation and invasion. Luciferase reporter assay was used to identify the targets of miR-195-5p. The results showed that miR-195-5p was significantly downregulated in osteosarcoma cells. Forced expression of miR-195-5p significantly inhibited cell proliferation, suppressed cell migration and invasion, compared with wild-type and control-transfected osteosarcoma cells. Luciferase reporter assay revealed that miR-195-5p binds to the 3'-untranslated region (UTR) of Naked cuticle homolog 1 (NKD1), indicating that NKD1 was a novel target of miR-195-5p. NKD1 mRNA and protein levels were reduced after overexpression of miR-195-5p. Moreover, silencing of NKD1 significantly inhibited the proliferation and invasion of osteosarcoma cells. Accordingly, our results support a tumor suppressor role of miR-195-5p in osteosarcoma through inhibiting NKD1, and it may be a promising therapeutic target for osteosarcoma.
© 2017 International Federation for Cell Biology.

Entities:  

Keywords:  NKD1; miR-195-5p; osteosarcoma; therapeutic target; tumor growth; tumor suppressor

Mesh:

Substances:

Year:  2017        PMID: 28032380     DOI: 10.1002/cbin.10723

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  12 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Characteristic miRNA expression signature and random forest survival analysis identify potential cancer-driving miRNAs in a broad range of head and neck squamous cell carcinoma subtypes.

Authors:  Yury O Nunez Lopez; Berta Victoria; Pawel Golusinski; Wojciech Golusinski; Michal M Masternak
Journal:  Rep Pract Oncol Radiother       Date:  2017-11-20

3.  miR-195 contributes to human osteoarthritis via targeting PTHrP.

Authors:  Xiaoming Cao; Zhiqing Duan; Zheyi Yan; Yongping Li; Lu Li; Jian Sun; Pengfei Han; Pengcui Li; Lei Wei; Xiaochun Wei
Journal:  J Bone Miner Metab       Date:  2018-11-21       Impact factor: 2.626

4.  miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells.

Authors:  Joao Paulo Bras; Andreia Machado Silva; George A Calin; Mario Adolfo Barbosa; Susana Gomes Santos; Maria Ines Almeida
Journal:  PLoS One       Date:  2017-11-22       Impact factor: 3.240

Review 5.  MicroRNA-195: a review of its role in cancers.

Authors:  Wanpeng Yu; Xiao Liang; Xiangdong Li; Yuan Zhang; Zhenqing Sun; Ying Liu; Jianxun Wang
Journal:  Onco Targets Ther       Date:  2018-10-17       Impact factor: 4.147

6.  Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway.

Authors:  Jun Dai; Rujia Wei; Peihai Zhang; Beihua Kong
Journal:  J Transl Med       Date:  2019-06-06       Impact factor: 8.440

7.  MicroRNA and mRNA Interaction Network Regulates the Malignant Transformation of Human Bronchial Epithelial Cells Induced by Cigarette Smoke.

Authors:  Jin Wang; Xiao-Fan Yu; Nan Ouyang; Shiyu Zhao; Haiping Yao; Xifei Guan; Jian Tong; Tao Chen; Jian-Xiang Li
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

8.  MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells.

Authors:  Li Chai; Xiao-Jing Kang; Zhen-Zhu Sun; Ming-Feng Zeng; Shi-Rong Yu; Yuan Ding; Jun-Qin Liang; Ting-Ting Li; Juan Zhao
Journal:  Cancer Manag Res       Date:  2018-05-03       Impact factor: 3.989

9.  MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells.

Authors:  Hongqin Wang; Shuxian Ren; Yongming Xu; Wang Miao; Xintao Huang; Zhizhao Qu; Jinhu Li; Xiaodong Liu; Pengzhou Kong
Journal:  Anticancer Drugs       Date:  2019-01       Impact factor: 2.248

10.  MicroRNA‑195 inhibits cell proliferation, migration and invasion by targeting defective in cullin neddylation 1 domain containing 1 in cervical cancer.

Authors:  Jinyan Zhong; Hui Yuan; Xiangqian Xu; Shoufang Kong
Journal:  Int J Mol Med       Date:  2018-05-08       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.